Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Digestive Evolution of Children With Crohn's Disease or Ulcerative Colitis Whose Anti-TNFα Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis,

View source ↗

Summary

A pediatric clinical trial evaluating outcomes for children with Crohn's disease or ulcerative colitis after switching from anti-TNF therapy to ustekinumab due …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelara (ustekinumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Chronic Inflammatory Bowel Diseases | Status: NOT_YET_RECRUITING